Chul Su Baek

Chul Su Baek is an accomplished inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of vascular leakage blockers. With a total of 2 patents to his name, Baek's work is characterized by innovation and a focus on high-quality drug substances.

Latest Patents

Baek's latest patents include a crystalline form of a vascular leakage blocker compound. This invention relates to a crystalline form of (E)-methyl 6-((3S,8S,9S,10R,13S,14S,17R)-3-(((5S,6R)-5-acetoxy-6-(acetoxytnethyl)-5,6-dihydro-2H-pyran-2-yl)oxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-yl)hept-5-enoate and a blood vessel leak blocker comprising the same. This novel crystalline form boasts high purity, excellent stability, and long-term pharmaceutical stability, making it advantageous for producing high-quality drug substances. Another significant patent is a preparation method of vascular leakage blockers with a high yield. This method is more productive and economical than conventional methods, utilizing an intermediate that effectively removes impurities generated during the reaction.

Career Highlights

Chul Su Baek is currently associated with Curacle Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the development of effective vascular leakage blockers, which are crucial for various medical applications.

Collaborations

Baek has collaborated with notable colleagues, including Koo Hyeon Ahn and Myung-Hwa Kim. These collaborations have further enhanced the quality and impact of his inventions.

Conclusion

Chul Su Baek's contributions to the field of pharmaceuticals, particularly in the area of vascular leakage blockers, demonstrate his commitment to innovation and quality. His patents reflect a deep understanding of the complexities involved in drug development, positioning him as a key figure in this important field.